Differential regulation of RGS proteins in the prefrontal cortex of short- and long-term human opiate abusers

Neuropharmacology

Volumn 62, Issue 2, 2012, Pages 1044-1051

  Rivero, Guadalupe ^a   Gabilondo, Ane M ^a,e   García Fuster, M Julia ^b,c   La Harpe, Romano ^d   García Sevilla, Jesús A ^b,c   Meana, J Javier ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^c Redes Temáticas de Investigación Cooperativa en Salud Red de Trastornos Adictivos   (Spain)

^d UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

^e Omnia Molecular SL   (Spain)

Author keywords

Opioid receptor; Human brain; Opiate addiction; RGS10; RGS4; RGS9

Indexed keywords

MORPHINE; NALOXONE; OPIATE; RGS PROTEIN; RGS10 PROTEIN; RGS4 PROTEIN; RGS9 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; DRUG TOLERANCE; FEMALE; GENDER; HUMAN; HUMAN TISSUE; IMMUNODETECTION; IMMUNOREACTIVITY; LONG TERM EXPOSURE; LONG TERM OPIATE ADDICTION; MALE; MOLECULAR WEIGHT; NEUROBIOLOGY; NONHUMAN; OPIATE ADDICTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MODIFICATION; RAT; SHORT TERM OPIATE ADDICTION; UPREGULATION; WITHDRAWAL SYNDROME;

ANIMALS; FEMALE; HUMANS; MALE; OPIOID-RELATED DISORDERS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; RGS PROTEINS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84855974099     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.10.015     Document Type: Article

References (62)

1. A.R. Albig, and W.P. Schiemann Identification and characterization of regulator of G protein signaling 4 (RGS4) as a novel inhibitor of tubulogenesis: RGS4 inhibits mitogen-activated protein kinases and vascular endothelial growth factor signaling Mol. Biol. Cell. 16 2005 609 625
2. S. Ammon, P. Mayer, U. Riechert, H. Tischmeyer, and V. Hollt Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal Brain Res. Mol. Brain Res. 112 2003 113 125
3. G. Bansal, K.M. Druey, and Z. Xie R4 RGS proteins: regulation of G-protein signaling and beyond Pharmacol. Ther. 116 2007 473 495
4. G.B. Bishop, W.E. Cullinan, E. Curran, and H.B. Gutstein Abused drugs modulate RGS4 mRNA levels in rat brain: comparison between acute drug treatment and a drug challenge after chronic treatment Neurobiol. Dis. 10 2002 334 343
5. S.A. Burchett In through the out door: nuclear localization of the regulators of G protein signaling J. Neurochem. 87 2003 551 559
6. P.G. Burgon, W.L. Lee, A.B. Nixon, E.G. Peralta, and P.J. Casey Phosphorylation and nuclear translocation of a regulator of G protein signaling (RGS10) J. Biol. Chem. 276 2001 32828 32834
7. 2+ channel inhibition in striatal cholinergic interneurons Proc. Natl. Acad. Sci. USA 101 2004 16339 16344
8. T.K. Chatterjee, and R.A. Fisher Cytoplasmic, nuclear, and golgi localization of RGS proteins. Evidence for N-terminal and RGS domain sequences as intracellular targeting motifs J. Biol. Chem. 275 2000 24013 24021
9. M.J. Clark, and J.R. Traynor Endogenous regulator of G protein signaling proteins reduce μ-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells J. Pharmacol. Exp. Ther. 312 2005 809 815
10. o. Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways J. Biol. Chem. 278 2003 9418 9425
11. L. Emilsson, P. Saetre, and E. Jazin Low mRNA levels of RGS4 splice variants in Alzheimer's disease: association between a rare haplotype and decreased mRNA expression Synapse 59 2006 173 176
12. H.A. Erdely, C.A. Tamminga, R.C. Roberts, and M.W. Vogel Regional alterations in RGS4 protein in schizophrenia Synapse 59 2006 472 479
13. P.V. Escribá, M. Sastre, and J.A. García-Sevilla Increased density of guanine nucleotide-binding proteins in the postmortem brains of heroin addicts Arch. Gen. Psychiatry 51 1994 494 501
14. M. Ferrer-Alcón, R. La Harpe, J. Guimón, and J.A. García-Sevilla Downregulation of neuronal cdk5/p35 in opioid addicts and opiate-treated rats: relation to neurofilament phosphorylation Neuropsychopharmacology 28 2003 947 955
15. M. Ferrer-Alcón, M.J. García-Fuster, R. La Harpe, and J.A. García-Sevilla Long-term regulation of signalling components of adenylyl cyclase and mitogen-activated protein kinase in the pre-frontal cortex of human opiate addicts J. Neurochem. 90 2004 220 230
16. 2-adrenoceptors in the rat brain: up-regulation of receptors associated with increased receptor appearance J. Neurochem. 64 1995 2590 2597
17. M.J. García-Fuster, A. Ramos-Miguel, G. Rivero, R. La Harpe, J.J. Meana, and J.A. García-Sevilla Regulation of the extrinsic and intrinsic apoptotic pathways in the prefrontal cortex of short- and long-term human opiate abusers Neuroscience 157 2008 105 119
18. J. Garzón, A. López-Fando, and P. Sánchez- Blázquez The R7 subfamily of RGS proteins assists tachyphylaxis and acute tolerance at μ-opioid receptors Neuropsychopharmacology 28 2003 1983 1990
19. J. Garzón, M. Rodríguez-Muñoz, and P. Sánchez-Blázquez Morphine alters the selective association between mu-opioid receptors and specific RGS proteins in mouse periaqueductal gray matter Neuropharmacology 48 2005 853 868
20. J. Garzón, M. Rodríguez-Muñoz, E. de la Torre-Madrid, and P. Sánchez-Blázquez Effector antagonism by the regulators of G protein signalling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS Psychopharmacology (Berl) 180 2005 1 11
21. J. Garzón, M. Rodríguez-Muñoz, A. López-Fando, and P. Sánchez-Blázquez Activation of mu-opioid receptors transfers control of Galpha subunits to the regulator of G-protein signaling RGS9-2: role in receptor desensitization J. Biol. Chem. 280 2005 8951 8960
22. Z. Georgoussi, L. Leontiadis, G. Mazarakou, M. Merkouris, K. Hyde, and H. Hamm Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the μ- and δ-opioid receptors regulate opioid receptor signaling Cell. Signal. 18 2006 771 782
23. S.J. Gold, Y.G. Ni, H.G. Dohlman, and E.J. Nestler Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain J. Neurosci. 17 1997 8024 8037
24. S.J. Gold, M.H. Han, A.E. Herman, Y.G. Ni, C.M. Pudiak, G.K. Aghajanian, R.J. Liu, B.W. Potts, S.M. Mumby, and E.J. Nestler Regulation of RGS proteins by chronic morphine in rat locus coeruleus Eur. J. Neurosci. 17 2003 971 980
25. J.G. Granneman, Y. Zhai, Z. Zhu, M.J. Bannon, S.A. Burchett, C.J. Schmidt, R. Andrade, and J. Cooper Molecular characterization of human and rat RGS 9L, a novel splice variant enriched in dopamine target regions, and chromosomal localization of the RGS 9 gene Mol. Pharmacol. 54 1998 687 694
26. C. Haller, S. Fillatreau, R. Hoffmann, and F. Agenes Structure, chromosomal localization and expression of the mouse regulator of G-protein signaling10 gene (mRGS10) Gene 297 2002 39 49
27. M.H. Han, W. Renthal, R.H. Ring, Z. Rahman, K. Psifogeorgou, D. Howland, S. Birnbaum, K. Young, R. Neve, E.J. Nestler, and V. Zachariou Brain region specific actions of regulator of G protein signaling 4 oppose morphine reward and dependence but promote analgesia Biol. Psychiatry 67 2010 761 769
28. S.B. Hooks, K. Martemyanov, and V. Zachariou A role of RGS proteins in drug addiction Biochem. Pharmacol. 75 2008 76 84
29. i GTPase activity Nature 383 1996 175 177
30. S.E. Hyman, R.C. Malenka, and E.J. Nestler Neural mechanisms of addiction: the role of reward-related learning and memory Annu. Rev. Neurosci. 29 2006 565 598
31. C. Larminie, P. Murdock, J.P. Walhin, M. Duckworth, K.J. Blumer, M.A. Scheideler, and M. Garnier Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system Brain Res. Mol. Brain Res. 122 2004 24 34
32. J.-K. Lee, M.K. McCoy, A.S. Harms, K.A. Ruhn, S.J. Gold, and M.G. Tansey Regulator of G-protein signaling 10 promotes dopaminergic neuron survival via regulation of the microglial inflammatory response J. Neurosci. 28 2008 8517 8528
33. D.A. Lewis The human brain revisited: opportunities and challenges in post-mortem studies of psychiatric disorders Neuropsychopharmacology 26 2002 143 154
34. A. López-Fando, M. Rodríguez-Muñoz, P. Sánchez-Blázquez, and J. Garzón Expression of neural RGS-R7 and Gβ5 proteins in response to acute and chronic morphine Neuropsychopharmacology 30 2005 99 110
35. J.J. Mancuso, Y. Qian, C. Long, G.-Y. Wu, and T.G. Wensel Distribution of RGS9-2 in neurons of the mouse striatum J. Neurochem. 112 2010 651 661
36. C. Marie-Claire, C. Courtin, B.P. Roques, and F. Noble Cytoskeletal genes regulation by chronic morphine treatment in rat striatum Neuropsychopharmacology 29 2004 2208 2215
37. 2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain Eur. J. Pharmacol. 518 2005 234 242
38. K. Mirnics, F.A. Middleton, G.D. Stanwood, D.A. Lewis, and P. Levitt Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia Mol. Psychiatry 6 2001 293 301
39. q/11 and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters Synapse 47 2003 58 65
40. T. Nakagawa, M. Minami, and M. Satoh Up-regulation of RGS4 mRNA by opioid receptor agonists in PC12 cells expressing cloned μ- or κ-opioid receptors Eur. J. Pharmacol. 433 2001 29 36
41. E.J. Nestler Molecular basis of long-term plasticity underlying addiction Nat. Rev. Neurosci. 2 2001 119 128
42. E.J. Nestler Common molecular and cellular substrates of addiction and memory Neurobiol. Learn. Mem. 78 2002 637 647
43. E.J. Nestler Molecular mechanisms of drug addiction Neuropharmacology 47 Suppl. 1 2004 24 32
44. E.J. Nestler, and G.K. Aghajanian Molecular and cellular basis of addiction Science 278 1997 58 63
45. A. Ozaita, P.V. Escribá, P. Ventayol, C. Murga, F. Mayor Jr., and J.A. García-Sevilla Regulation of G protein-coupled receptor kinase 2 in brains of opiate-treated rats and human opiate addicts J. Neurochem. 70 1998 1249 1257
46. K. Psifogeorgou, P. Papakosta, S.J. Russo, R.L. Neve, D. Kardassis, S.J. Gold, and V. Zachariou RGS9-2 is a negative modulator of μ-opioid receptor function J. Neurochem. 103 2007 617 625
47. K. Psifogeorgou, D. Terzi, M.M. Papachazaki, A. Varidaki, D. Ferguson, S.J. Gold, and V. Zachariou A unique role of GRS9-2 in the striatum as a positive or negative regulator of opiate analgesia J. Neurosci. 31 2011 5617 5624
48. Z. Rahman, S.J. Gold, M.N. Potenza, C.W. Cowan, Y.G. Ni, W. He, T.G. Wensel, and E.J. Nestler Cloning and characterization of RGS9-2: a striatal-enriched alternatively spliced product of the RGS9 gene J. Neurosci. 19 1999 2016 2026
49. Z. Rahman, J. Schwarz, S.J. Gold, V. Zachariou, M.N. Wein, K.-H. Choi, A. Kovoor, C.-K. Chen, R.J. DiLeone, S.C. Schwarz, D.E. Selley, L. Sim-Selley, M. Barrot, R.R. Luedtke, D. Self, R.L. Neve, H.A. Lester, M.I. Simon, and E.J. Nestler RGS9 modulates dopamine signaling in the basal ganglia Neuron 38 2003 941 952
50. A. Ramos-Miguel, M.J. García-Fuster, L.F. Callado, R. La Harpe, J.J. Meana, and J.A. García-Sevilla Phosphorylation of FADD (Fas-associated death domain protein) at serine 194 is increased in the prefrontal cortex of opiate abusers: relation to mitogen activated protein kinase, phosphoprotein enriched in astrocytes of 15 kDa, and Akt signaling pathways involved in neuroplasticity Neuroscience 161 2009 23 38
51. G. Rivero, A.M. Gabilondo, J.A. García-Sevilla, R. La Harpe, B. Morentín, and J.J. Meana Characterization of regulators of G-protein signaling RGS4 and RGS10 proteins in the postmortem human brain Neurochem. Int. 57 2010 722 729
52. P.B. Shelat, A.P. Coulibaly, Q. Wang, A.Y. Sun, G.Y. Sun, and A. Simonyi Ischemia-induced increase in RGS7mRNA expression in gerbil hippocampus Neurosci. Lett. 403 2006 157 161
53. S. Shichinohe, H. Ozawa, E. Hashimoto, T. Tatschner, P. Riederer, and T. Saito Changes in the cAMP-related signal transduction mechanism in potmortem human brains of heroin addicts J. Neural. Transm. 108 2001 335 347
54. M. Simonato The neurochemistry of morphine addiction in the neocortex Trends Pharmacol. Sci. 17 1996 410 415
55. P.K. Smith, R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimoto, N.M. Goeke, B.J. Olson, and D.C. Klenk Measurement of protein using bicinchoninic acid Anal. Biochem. 150 1985 76 85
56. P.K. Tekumalla, F. Calon, Z. Rahman, S. Birdi, A.H. Rajput, O. Hornykiewicz, T. Di Paolo, P.J. Bedard, and E.J. Nestler Elevated levels of ΔFosB and RGS9 in striatum in Parkinson's disease Biol. Psychiatry 50 2001 813 816
57. J. Traynor Regulator of G protein-signaling proteins and addictive drugs Ann. N.Y. Acad. Sci. 1187 2010 341 352
58. P. Ventayol, X. Busquets, and J.A. García-Sevilla Modulation of immunoreactive protein kinase C-α and β isoforms and G proteins by acute and chronic treatments with morphine and other opiate drugs in rat brain Naunyn Schmiedeberg's Arch. Pharmacol. 355 1997 491 500
59. Q. Wang, and J.R. Traynor Opioid-induced down-regulation of RGS4: role of ubiquitination and implications for receptor cross-talk J. Biol. Chem. 286 2011 7854 7864
60. J.T. Williams, M.J. Christie, and O. Manzoni Cellular and synaptic adaptations mediating opioid dependence Physiol. Rev. 81 2001 299 343
61. q-mediated activation of mitogen-activated protein kinase and phosphoinositide synthesis J. Biol. Chem. 272 1997 11924 11927
62. V. Zachariou, D. Georgescu, N. Sánchez, Z. Rahman, R. DiLeone, O. Berton, R.L. Neve, L.J. Sim-Selley, D.E. Selley, S.J. Gold, and E.J. Nestler Essential role for RGS9 in opiate action Proc. Natl. Acad. Sci. USA 100 2003 13656 13661